182 related articles for article (PubMed ID: 26408255)
1. Modeling selective elimination of quiescent cancer cells from bone marrow.
Cavnar SP; Rickelmann AD; Meguiar KF; Xiao A; Dosch J; Leung BM; Cai Lesher-Perez S; Chitta S; Luker KE; Takayama S; Luker GD
Neoplasia; 2015 Aug; 17(8):625-33. PubMed ID: 26408255
[TBL] [Abstract][Full Text] [Related]
2. A Facile, In Vitro 384-Well Plate System to Model Disseminated Tumor Cells in the Bone Marrow Microenvironment.
Buschhaus JM; Luker KE; Luker GD
Methods Mol Biol; 2018; 1686():201-213. PubMed ID: 29030823
[TBL] [Abstract][Full Text] [Related]
3. Targeting disseminated estrogen-receptor-positive breast cancer cells in bone marrow.
Buschhaus JM; Humphries BA; Eckley SS; Robison TH; Cutter AC; Rajendran S; Haley HR; Bevoor AS; Luker KE; Luker GD
Oncogene; 2020 Aug; 39(34):5649-5662. PubMed ID: 32678295
[TBL] [Abstract][Full Text] [Related]
4. A genetically engineered oncolytic adenovirus decoys and lethally traps quiescent cancer stem-like cells in S/G2/M phases.
Yano S; Tazawa H; Hashimoto Y; Shirakawa Y; Kuroda S; Nishizaki M; Kishimoto H; Uno F; Nagasaka T; Urata Y; Kagawa S; Hoffman RM; Fujiwara T
Clin Cancer Res; 2013 Dec; 19(23):6495-505. PubMed ID: 24081978
[TBL] [Abstract][Full Text] [Related]
5. A polymer microstructure array for the formation, culturing, and high throughput drug screening of breast cancer spheroids.
Markovitz-Bishitz Y; Tauber Y; Afrimzon E; Zurgil N; Sobolev M; Shafran Y; Deutsch A; Howitz S; Deutsch M
Biomaterials; 2010 Nov; 31(32):8436-44. PubMed ID: 20692698
[TBL] [Abstract][Full Text] [Related]
6. In vivo/ex vivo and in situ assays used in cancer research: a brief review.
Teicher BA
Toxicol Pathol; 2009 Jan; 37(1):114-22. PubMed ID: 19098118
[TBL] [Abstract][Full Text] [Related]
7. Establishment and Analysis of a 3D Co-Culture Spheroid Model of Pancreatic Adenocarcinoma for Application in Drug Discovery.
Meier-Hubberten JC; Sanderson MP
Methods Mol Biol; 2019; 1953():163-179. PubMed ID: 30912022
[TBL] [Abstract][Full Text] [Related]
8. Impact of the spheroid model complexity on drug response.
Hoffmann OI; Ilmberger C; Magosch S; Joka M; Jauch KW; Mayer B
J Biotechnol; 2015 Jul; 205():14-23. PubMed ID: 25746901
[TBL] [Abstract][Full Text] [Related]
9. 3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions.
Wenzel C; Riefke B; Gründemann S; Krebs A; Christian S; Prinz F; Osterland M; Golfier S; Räse S; Ansari N; Esner M; Bickle M; Pampaloni F; Mattheyer C; Stelzer EH; Parczyk K; Prechtl S; Steigemann P
Exp Cell Res; 2014 Apr; 323(1):131-143. PubMed ID: 24480576
[TBL] [Abstract][Full Text] [Related]
10. 3D models of epithelial-mesenchymal transition in breast cancer metastasis: high-throughput screening assay development, validation, and pilot screen.
Li Q; Chen C; Kapadia A; Zhou Q; Harper MK; Schaack J; LaBarbera DV
J Biomol Screen; 2011 Feb; 16(2):141-54. PubMed ID: 21297102
[TBL] [Abstract][Full Text] [Related]
11. Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system.
Karlsson H; Fryknäs M; Larsson R; Nygren P
Exp Cell Res; 2012 Aug; 318(13):1577-85. PubMed ID: 22487097
[TBL] [Abstract][Full Text] [Related]
12. Chemo-sensitivity of Two-dimensional Monolayer and Three-dimensional Spheroid of Breast Cancer MCF-7 Cells to Daunorubicin, Docetaxel, and Arsenic Disulfide.
Uematsu N; Zhao Y; Kiyomi A; Yuan BO; Onda K; Tanaka S; Sugiyama K; Sugiura M; Takagi N; Hayakawa A; Hirano T
Anticancer Res; 2018 Apr; 38(4):2101-2108. PubMed ID: 29599328
[TBL] [Abstract][Full Text] [Related]
13. Liquid-based three-dimensional tumor models for cancer research and drug discovery.
Ham SL; Joshi R; Thakuri PS; Tavana H
Exp Biol Med (Maywood); 2016 May; 241(9):939-54. PubMed ID: 27072562
[TBL] [Abstract][Full Text] [Related]
14. Robotic production of cancer cell spheroids with an aqueous two-phase system for drug testing.
Ham SL; Atefi E; Fyffe D; Tavana H
J Vis Exp; 2015 Apr; (98):e52754. PubMed ID: 25939084
[TBL] [Abstract][Full Text] [Related]
15. Transparent and Gas-Permeable Liquid Marbles for Culturing and Drug Sensitivity Test of Tumor Spheroids.
Li H; Liu P; Kaur G; Yao X; Yang M
Adv Healthc Mater; 2017 Jul; 6(13):. PubMed ID: 28426154
[TBL] [Abstract][Full Text] [Related]
16. High-content assays for characterizing the viability and morphology of 3D cancer spheroid cultures.
Sirenko O; Mitlo T; Hesley J; Luke S; Owens W; Cromwell EF
Assay Drug Dev Technol; 2015 Sep; 13(7):402-14. PubMed ID: 26317884
[TBL] [Abstract][Full Text] [Related]
17. A 3D Heterotypic Multicellular Tumor Spheroid Assay Platform to Discriminate Drug Effects on Stroma versus Cancer Cells.
Weydert Z; Lal-Nag M; Mathews-Greiner L; Thiel C; Cordes H; Küpfer L; Guye P; Kelm JM; Ferrer M
SLAS Discov; 2020 Mar; 25(3):265-276. PubMed ID: 31658853
[TBL] [Abstract][Full Text] [Related]
18. In vitro co-culture model of medulloblastoma and human neural stem cells for drug delivery assessment.
Ivanov DP; Parker TL; Walker DA; Alexander C; Ashford MB; Gellert PR; Garnett MC
J Biotechnol; 2015 Jul; 205():3-13. PubMed ID: 25592050
[TBL] [Abstract][Full Text] [Related]
19. Imaging Sensitivity of Quiescent Cancer Cells to Metabolic Perturbations in Bone Marrow Spheroids.
Cavnar SP; Xiao A; Gibbons AE; Rickelmann AD; Neely T; Luker KE; Takayama S; Luker GD
Tomography; 2016 Jun; 2(2):146-157. PubMed ID: 27478871
[TBL] [Abstract][Full Text] [Related]
20. Alginate-based microfluidic system for tumor spheroid formation and anticancer agent screening.
Chen MC; Gupta M; Cheung KC
Biomed Microdevices; 2010 Aug; 12(4):647-54. PubMed ID: 20237849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
